Women who use combined oral contraceptives containing estrogen and progestogen have an associated two- to eight-fold increased risk of venous thromboembolism. Over the years, in an attempt to reduce ...
Oral contraceptives and hormonal therapies represent a cornerstone of reproductive healthcare, offering effective prevention of unwanted pregnancies and providing therapeutic benefits for a range of ...
A large portion of women in the U.S. take oral contraceptive pills to prevent pregnancy and manage menstruation. New research by Handy and colleagues (2023) published in The Journal of Sexual Medicine ...
Reassuringly, a history of oral contraceptive use had no deleterious effects on cardiovascular disease (CVD) and survival over long-term follow-up, a U.K. Biobank study showed. In a comparison between ...
Add Yahoo as a preferred source to see more of our stories on Google. Online orders for Opill — the first oral contraceptive to be dispensed without a prescription in the U.S. — began March 18, CNN ...
New research presented today at the European Stroke Organisation Conference (ESOC) 2025 revealed that the use of combined oral contraceptives (OCs) is associated with a threefold increase in the risk ...
All hormonal contraceptives carry a small increased risk of breast cancer. A new study is offering more information for women about whether the type of birth control they take increases their risk of ...
States with abortion restrictions triggered by the Dobbs decision saw a decline in prescriptions of oral contraceptives -- particularly emergency contraceptives -- a cohort study showed. The most ...
Hosted on MSN
Combined oral contraceptive use among people with migraine with aura persists despite cautions
Current medical guidelines discourage the use of combined oral contraceptives (COCs) among people who experience migraine with aura—a type of migraine accompanied by temporary neurological ...
A 28-year-old nulliparous woman presents for follow-up with the chief complaint of persistent dysmenorrhea that was progressing and severe dyspareunia. At age 16, she first reported heavy menstrual ...
The van Hylckama Vlieg study was a population case-control study of premenopausal women aged 18-50 years, based on data from the Multiple Environment and Genetic Assessment of Risk Factors for Venous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results